tiprankstipranks
Trending News
More News >
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Crinetics Pharmaceuticals (CRNX) Income Statement

Compare
721 Followers

Crinetics Pharmaceuticals Income Statement

Last quarter (Q3 2025), Crinetics Pharmaceuticals's total revenue was $143.00K, an increase of Infinity% from the same quarter last year. In Q3, Crinetics Pharmaceuticals's net income was $-130.09M. See Crinetics Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.04M$ 4.01M$ 4.74M$ 1.08M$ 71.00K
Gross Profit
$ -1.75M$ 4.01M$ 4.74M$ 1.08M$ -56.93M
Operating Expenses
$ 337.11M$ 226.62M$ 172.62M$ 108.78M$ 18.03M
Depreciation and Amortization
$ 2.79M$ 1.10M$ 983.00K$ 922.00K$ 948.00K
EBITDA
$ -336.07M$ -221.51M$ -166.90M$ -106.78M$ -74.00M
Operating Income
$ -338.85M$ -222.61M$ -167.88M$ -107.70M$ -74.95M
Other Income/Expenses
$ 40.45M$ 8.08M$ 3.96M$ 61.00K$ 1.14M
Pretax Income
$ -298.41M$ -214.53M$ -163.92M$ -107.64M$ -73.81M
Net Income
$ -298.41M$ -214.53M$ -163.92M$ -107.64M$ -73.81M
Per Share Metrics
Basic EPS
$ -3.69$ -3.69$ -3.15$ -2.80$ -2.42
Diluted EPS
$ -3.69$ -3.69$ -3.15$ -2.80$ -2.42
Weighted Average Shares Outstanding
80.78M 58.07M 51.98M 38.44M 30.45M
Weighted Average Shares Outstanding (Diluted)
80.78M 58.07M 51.98M 38.44M 30.45M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History